S
SAB Biotherapeutics, Inc. (SABS)
NCM – Real vaqt narxi. Valyuta: USD
3.80
-0.07 (-1.81%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
3.81
+0.01 (0.34%)
Bozordan keyin: Jun 26, 2026, 7:14 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
3.80
-0.07 (-1.81%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
3.81
+0.01 (0.34%)
Bozordan keyin: Jun 26, 2026, 7:14 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Kompaniyaning naqd pul zahiralari $20.5M umumiy qarzdan $6.2M sezilarli darajada ko'p bo'lib, kuchli moliyaviy moslashuvchanlikni ta'minlaydi
Jami joriy aktivlar $112.8M jami joriy majburiyatlardan $9.9M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (0.0) tarmoq o'rtachasidan (0.3) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz qoplash koeffitsiyenti (-318.7x) xavfli darajada past bo'lib, qarzni qaytarish xavflarini ko'rsatadi
Salbiy erkin pul oqimi -$15.3M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 11.45 | 6.05 | 10 | |
| Tezkor likvidlik nisbati | 11.45 | 5.63 | 10 | |
| Qarz/Kapital nisbati | 0.03 | 0.30 | 9.0 | |
| Qarz/Aktivlar nisbati | 0.02 | 1.04 | 9.0 | |
| Foiz to‘lov qoplami | -318.71 | -16.91 | 1.0 | |
| O‘rtacha ball | 7.8 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 24M | 2M | 1M | N/A | N/A |
| Yalpi foyda | 21M | -2M | -3M | -3M | -3M |
| Operatsion daromad | -29M | -38M | -43M | -49M | -58M |
| Sof foyda | -19M | -42M | -34M | 4M | -26M |
| EBITDA | -26M | -34M | -38M | -46M | -55M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | N/A | 75.29 | 5.5 |
| Keyingi chorak | N/A | -23.64 | 1.0 |
| Joriy yil | N/A | -22.2 | 1.0 |
| Keyingi yil | N/A | 31.34 | 5.5 |
| O‘rtacha ball | 3.3 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 999 | -563.12 | -29.62 | 13.87 | 5.0 |
| Yil/Yil | 999 | -263.08 | 37.5 | -95.63 | 5.5 |
| 3 yil o‘rtacha | -77.17 | 2.18 | 17.57 | -22.51 | 3.5 |
| 5 yil o‘rtacha | 141.35 | -37.59 | 21.11 | -96.41 | 5.5 |
| O‘rtacha ball | 4.9 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |